APA (7th ed.) Citation

Robby, A. I., Kim, E. H., Huh, K. M., Jin, E., Park, K. D., & Park, S. Y. (2025). Mevalonate pathway-triggered phase transition of injectable hydrogel for cholesterol-downregulated therapy of osteoarthritis. KeAi Communications Co., Ltd.

Chicago Style (17th ed.) Citation

Robby, Akhmad Irhas, Ee Hyun Kim, Kang Moo Huh, Eun-Jung Jin, Ki Dong Park, and Sung Young Park. Mevalonate Pathway-triggered Phase Transition of Injectable Hydrogel for Cholesterol-downregulated Therapy of Osteoarthritis. KeAi Communications Co., Ltd, 2025.

MLA (9th ed.) Citation

Robby, Akhmad Irhas, et al. Mevalonate Pathway-triggered Phase Transition of Injectable Hydrogel for Cholesterol-downregulated Therapy of Osteoarthritis. KeAi Communications Co., Ltd, 2025.